Stronger T cell activation may be achieved by engineering cancer cells to overexpress cytokines. To increase T cell activation and give your cancer cells the results you want, Creative Biolabs provides a full solution for engineering cancer cells with cytokine overexpression. Our team of specialists has experience controlling the growth and development of cancer cells utilizing cytokines. Cytokines are used to stimulate or inhibit the immune system's response to cancer as well as to promote or hinder the growth of cancer cells. By enabling the creation of cancer cells with increased cytokine expression, which can then be used to activate T cells and boost the immune response against cancer, this service will offer a potent tool for cancer immunotherapy. This service will provide a powerful tool for cancer immunotherapy, as it will enable the generation of cancer cells with increased expression of cytokines, which can then be used to activate T cells and enhance the immune response against cancer.
Cytokines are small proteins that play a role in cell signaling and have the ability to influence the growth and development of cancer cells. Cytokines have the ability to either promote or stop the proliferation of cancer cells depending on the situation. Furthermore, cytokines can influence how the immune system reacts to cancer by either triggering the immune system to attack the cancer cells or by inhibiting the immune system's reaction to the cancer cells.
Furthermore, cytokines are crucial for the activation of T cells and can influence this process. Interleukins, one of the substances that can be produced as a result of cytokines, are able to activate T cells. Moreover, cytokines have the capacity to attach to receptors found on the surface of T cells, which can then influence the activation of the T cells.
Fig.1 Mechanism of T cell activation and cancer cell killing. (Hollingsworth & Jansen, 2019)
There are several strategies for cancer cell engineering. Cytokine-based approaches involve using cytokines to manipulate the growth and development of cancer cells, as well as to stimulate or suppress the immune system's response to cancer. Typically, The overall procedure often goes like this:
With the patient's tissue sample, we will first separate the cancer cells and cultivate them in the lab. The desired cytokine gene will subsequently be inserted into the cancer cells using gene editing procedures. Finally, flow cytometry will be used to assess the cytokine expression in the modified cancer cells.
Currently, we provide the following cytokines for cancer cell engineering:
Perhaps you need to know something else? Please contact us directly for more information and we look forward to discussing it with you.
Reference
For Research Use Only | Not For Clinical Use
Download our brochure